Dong‐Joo Cheon

2.5k total citations
30 papers, 1.6k citations indexed

About

Dong‐Joo Cheon is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dong‐Joo Cheon has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Dong‐Joo Cheon's work include Cancer Cells and Metastasis (6 papers), Cancer Research and Treatments (5 papers) and Cell Adhesion Molecules Research (5 papers). Dong‐Joo Cheon is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer Research and Treatments (5 papers) and Cell Adhesion Molecules Research (5 papers). Dong‐Joo Cheon collaborates with scholars based in United States, Japan and South Korea. Dong‐Joo Cheon's co-authors include Sandra Oršulić, Sameera Nallanthighal, James Patrick Heiserman, Beth Y. Karlan, Ann E. Walts, Jessica A. Beach, Jenny Lester, Miran Rada, Dror Berel and Xiaojiang Cui and has published in prestigious journals such as Nano Letters, PLoS ONE and Cancer Research.

In The Last Decade

Dong‐Joo Cheon

29 papers receiving 1.6k citations

Peers

Countries citing papers authored by Dong‐Joo Cheon

Since Specialization

Citations

This map shows the geographic impact of Dong‐Joo Cheon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Joo Cheon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Joo Cheon more than expected).

Fields of papers citing papers by Dong‐Joo Cheon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Joo Cheon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Joo Cheon. The network helps show where Dong‐Joo Cheon may publish in the future.

Co-authorship network of co-authors of Dong‐Joo Cheon

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Joo Cheon. A scholar is included among the top collaborators of Dong‐Joo Cheon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Joo Cheon. Dong‐Joo Cheon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lipid droplet-associated hydrolase (LDAH) knockdown enhances TAG hydrolysis and promotes ovarian cancer progression and chemoresistance 2025 ·Oncogenesis ·(unknown), Sameera Nallanthighal, (unknown), (unknown), Antoni Paul, Young‐Hwa Goo, Dong‐Joo Cheon	0
2	Targeting Heat Shock Protein 27 and Fatty Acid Oxidation Augments Cisplatin Treatment in Cisplatin-Resistant Ovarian Cancer Cell Lines 2023 ·International Journal of Molecular Sciences ·James Patrick Heiserman, (unknown), (unknown), Dong‐Joo Cheon	8
3	Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets 2022 ·Cancers ·Ralf‐Peter Czekay, Dong‐Joo Cheon, Rohan Samarakoon, Stacie M. Kutz, Paul J. Higgins	74
4	HOXB13 controls cell state through super-enhancers 2020 ·Experimental Cell Research ·Paul‐Joseph Aspuria, Dong‐Joo Cheon, Maricel Gozo, Jessica A. Beach, (unknown), Ann E. Walts, Beth Y. Karlan, Sandra Oršulić	9
5	Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer 2020 ·Cell Death and Disease ·Sameera Nallanthighal, Miran Rada, James Patrick Heiserman, Jennifer Cha, (unknown), Bo Zhou, Wei Yang, Ye Hu, (unknown), (unknown), Zahra Ashkavand, Kenneth R. Norman, Sandra Oršulić, Dong‐Joo Cheon	64
6	The Role of the Extracellular Matrix in Cancer Stemness 2019 ·Frontiers in Cell and Developmental Biology ·Sameera Nallanthighal, James Patrick Heiserman, Dong‐Joo Cheon	261
7	Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer 2018 ·Oncogene ·Miran Rada, Sameera Nallanthighal, Jennifer Cha, (unknown), (unknown), (unknown), (unknown), Sandra Oršulić, Dong‐Joo Cheon	79
8	Intracellular Delivery of Nanomaterials via an Inertial Microfluidic Cell Hydroporator 2018 ·Nano Letters ·Yanxiang Deng, Megan E. Kizer, Miran Rada, (unknown), Xing Wang, Dong‐Joo Cheon, Aram J. Chung	76
9	Abstract TMEM-017: COLLAGEN TYPE XI ALPHA 1 (COL11A1) IS A NOVEL STROMAL MEDIATOR OF CHEMORESISTANCE 2017 ·Clinical Cancer Research ·Miran Rada, (unknown), (unknown), Sandra Oršulić, Dong‐Joo Cheon	1
10	A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets 2016 ·Cancer Letters ·Dongyu Jia, Zhenqiu Liu, Nan Deng, Tuan Zea Tan, Ruby Yun‐Ju Huang, Barbie Taylor‐Harding, Dong‐Joo Cheon, Kate Lawrenson, (unknown), Ann E. Walts, Beth Y. Karlan, Sandra Oršulić	83
11	ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma 2015 ·Carcinogenesis ·Dong‐Joo Cheon, Andrew J. Li, Jessica A. Beach, Ann E. Walts, Hang Tran, Jenny Lester, Beth Y. Karlan, Sandra Oršulić	21
12	Sphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancer 2015 ·Oncotarget ·Jessica A. Beach, Paul‐Joseph Aspuria, Dong‐Joo Cheon, Kate Lawrenson, Hasmik Agadjanian, Christine Walsh, Beth Y. Karlan, Sandra Oršulić	48
13	Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas 2014 ·The Journal of Pathology Clinical Research ·Dong‐Joo Cheon, Ann E. Walts, Jessica A. Beach, Jenny Lester, John S. Bomalaski, Christine Walsh, W. Ruprecht Wiedemeyer, Beth Y. Karlan, Sandra Oršulić	17
14	A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer 2013 ·Clinical Cancer Research ·Dong‐Joo Cheon, Yunguang Tong, Myung‐Shin Sim, Judy Dering, Dror Berel, Xiaojiang Cui, Jenny Lester, Jessica A. Beach, Mourad Tighiouart, Ann E. Walts, Beth Y. Karlan, Sandra Oršulić	265
15	Abstract 329: A mouse model of epithelial ovarian cancer with defined oncogenic drivers. 2013 ·Cancer Research ·Hasmik Agadjanian, Dong‐Joo Cheon, (unknown), Anna Laury, Carl W. Miller, Beth Y. Karlan, Sandra Oršulić, Christine Walsh	2
16	Abstract B48: Targeting chemo-resistance in CCNE1-amplified ovarian cancer 2013 ·Clinical Cancer Research ·Barbie Taylor‐Harding, Hasmik Agadjanian, (unknown), Takako Mizuno, Dong‐Joo Cheon, Sandra Oršulić, Beth Y. Karlan, Christine Walsh, (unknown)	1
17	Mouse Models of Cancer 2011 ·Annual Review of Pathology Mechanisms of Disease ·Dong‐Joo Cheon, Sandra Oršulić	273
18	Whole ovary immunohistochemistry for monitoring cell proliferation and ovulatory wound repair in the mouse 2010 ·Reproductive Biology and Endocrinology ·(unknown), (unknown), Dong‐Joo Cheon, Sandra Oršulić	17
19	CA125/MUC16 Is Dispensable for Mouse Development and Reproduction 2009 ·PLoS ONE ·Dong‐Joo Cheon, Ying Wang, Jian Min Deng, Zhen Lü, Lianchun Xiao, Chun‐Ming Chen, Robert C. Bast, Richard R. Behringer	28
20	MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse 2008 ·Differentiation ·Ying Wang, Dong‐Joo Cheon, Zhen Lü, (unknown), Chun‐Ming Chen, Robert Z. Luo, Deyin Xing, Sandra Oršulić, Robert C. Bast, Richard R. Behringer	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact